Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
S. Loi
Based on 12 articles published since 2008
||||
Expertise Level
The expertise of S. Loi ranks in the
  • Top 1.3%
  • ... of 259,089 published authors worldwide on Breast Neoplasms
  • ... from 2008 through 2019
  • ... based on contributions to 12 articles on the topic.
Graphical view (beta)
Uncounted papers?
Work Locations
Details
Most likely:    Peter MacCallum Cancer Centre      
2017
  • Department of Pathology, European Institute of Oncology, Milan. · School of Medicine, University of Milan, Milan. · Cancer Prevention and Genetics, European Institute of Oncology, Milan. · Epidemiology and Biostatistics, European Institute of Oncology, Milan. · Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan. · Division of Medical Oncology, E.O. Ospedali Galliera, Genoa. · Experimental Therapeutics European Institute of Oncology, Milan. · Division of Senology, European Institute of Oncology, Milan, Italy. · Department of Pathology, GZA, Breast Cancer Translational Research Group, Jules Bordet Institute, Brussels. · Molecular Immunology Lab, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre University of Melbourne, East Melbourne, Victoria, Australia. · Institute of Pathology Charité University Hospital, Berlin, Germany and German Cancer Consortium, Berlin, Germany. · Pubmed 28426105
  • Department of Breast Medical Oncology, Yale University, Yale Cancer Center, New Haven, USA. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Frontier Science, Inverness, Scotland. · Breast Center, Department of Obstetrics and Gynecology, University of Munich, Germany. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Spanish Breast Cancer Cooperative Group SOLTI, Barcelona, Spain. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Australia. · Hospital Moinhos de Vento, Porto Alegre, Brazil. · Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada. · The Christie/NIHR Clinical Research Facility, Manchester, UK. · Department of Breast Surgery, Kyoto University Hospital, Kyoto, Japan. · Department of Obstetrics and Gynecology, Campus Kiel, University Hospital Kiel, Kiel, Germany. · Novartis, Cambridge. · Memorial Sloan-Kettering Cancer Center, Memorial Hospital, New York, USA. · Pubmed 28177460
  • Peter MacCallum Cancer Centre, Melbourne. · Latrobe Regional Hospital, Traralgon. · University of Melbourne, Melbourne, Australia. · Pubmed 28430863
2016
  • Department of Obstetrics and Gynecology, Brustzentrum der Universität München, München (LMU), Germany · Pfizer Inc, New York, USA. · Department of Molecular Oncology, Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Department of Medical Oncology, Thomas Jefferson University, Philadelphia, USA. · Department of Medicine, National Cancer Center, Goyang-si, Korea. · Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. · Department of Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia. · Department of Medicine, Sunnybrook Odette Cancer Centre, Toronto, Canada. · Department of Transfusion, Aichi Cancer Center Hospital, Nagoya, Japan. · Pfizer Inc, Cambridge, USA. · Department of Oncology, German Breast Group Forschungs GmbH, Neu-Isenburg, Germany. · Pubmed 27029704
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Free University of Bruxelles, Brussels, Belgium. · Oncology Biomarker Development, Genentech Inc., South San Francisco, CA, USA. · Department of Biostatistics, Genentech Inc., South San Francisco, CA, USA. · Division of Early Drug Development for Innovative Therapies, European Institute of Oncology, Milan, Italy. · Department of Pathology, Institut Jules Bordet, Brussels, Belgium. · Breast International Group, Brussels, Belgium. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Division of Medical Oncology, Institut Jules Bordet, Brussels, Belgium. · Division of Biostatistics and Epidemiology, Institut Gustave Roussy, Villejuif, France INSERM U1018, CESP, University of Paris, Villejuif, France. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Free University of Bruxelles, Brussels, Belgium Division of Medical Oncology, Institut Jules Bordet, Brussels, Belgium. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia · Pubmed 27672107
  • German Breast Group, Neu-Isenburg, Germany · The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Surgery, Oncology and Gastroenterology, University of Padua, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · German Breast Group, Neu-Isenburg, Germany. · Frontier Science Scotland, Kincraig, UK. · Department of Medical Oncology, University of Verona, Verona, Italy. · Institute of Pathology, Charité Universitätsmedizin Berlin, and German Cancer Consortium (DKTK), Berlin. · Department of Obstetrics and Gynecology, University Hospital Kiel, Kiel, Germany. · Institut Jules Bordet, Université Libre de Bruxelles, Brussel, Belgium. · Peter MacCallum Cancer Centre, East Melbourne, Australia. · Department of Obstetrics and Gynecology, Helios-Klinikum, Berlin-Buch, Germany. · Memorial Sloan-Kettering Cancer Center, New York, USA. · Pubmed 27177864
2015
  • Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet, Brussels Department of Pathology and TCRU, GZA, Antwerp, Belgium. · Institute of Pathology, Charité -University Hospital, Berlin, Germany. · Perlmutter Cancer Center, New York University Medical School, New York, USA. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · European Institute of Oncology (IEO) and University of Milan, Milan, Italy. · Department of Pathology GZA, TCRU Hospitals and CORE Antwerp University, Antwerp, Belgium. · Genomic Health, Inc., Redwood City, USA University of California San Francisco, San Francisco, USA. · Clermont-Ferrand Biopathology, University of Auvergne, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · Division of Haematology/Medical Oncology and. · Department of Cancer Biology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Jacksonville. · Department of Pathology, The UT M.D. Anderson Cancer Center, Boston. · Department of Pathology, Brigham and Women's Hospital, Boston Department of Cancer Biology, Dana Farber Cancer Institute, Boston. · Department of Cancer Biology, Dana Farber Cancer Institute, Boston Department of Cancer Biology, Harvard Medical School, Boston, USA. · Istituto Europeo di Oncologia, Milan, Italy. · Genomic Health, Inc., Redwood City, USA. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels. · Department of Pathology, University Hospital Leuven, Leuven, Belgium. · Department of Medicine, Department of Obstetrics and Gynecology and Women's Health, Albert Einstein Medical Center, Bronx, USA. · Laboratory Medicine Program, University Health Network, University of Toronto, Toronto. · Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, Canada. · Department of Pathology, Yale University School of Medicine, New Haven. · Department of Pathology, Stanford University Medical Centre, Stanford. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, USA. · German Breast Group, Neu-Isenburg, Germany. · Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan, Italy. · Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, USA. · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Victoria, Australia · Pubmed 25214542
  • Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia · Pubmed 26487579
2014
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne,Australia · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium Service de Biostatistique et D'Epidemiology, Gustave Roussy, Universite Paris-Sud, Villejuif, France. · Department of Anatomical Pathology, Institut Jules Bordet, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Oncology, Tampere University Hospital, Tampere. · Department of Oncology, Helsinki University Central Hospital, Helsinki. · Cancer Center, Kuopio University Hospital, Kuopio, Finland. · Department of Medicine, Institut Jules Bordet, Brussels, Belgium. · German Breast Group, Neu-Isenburg. · Charité University Hospital, Institute of Pathology, Berlin, Germany. · Immunology in Cancer and Infection Laboratory, Queensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute; School of Medicine, University of Queensland, Herston, Australia. · Pubmed 24608200
Probable:    University of Melbourne      
2017
  • Department of Pathology, European Institute of Oncology, Milan. · School of Medicine, University of Milan, Milan. · Cancer Prevention and Genetics, European Institute of Oncology, Milan. · Epidemiology and Biostatistics, European Institute of Oncology, Milan. · Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan. · Division of Medical Oncology, E.O. Ospedali Galliera, Genoa. · Experimental Therapeutics European Institute of Oncology, Milan. · Division of Senology, European Institute of Oncology, Milan, Italy. · Department of Pathology, GZA, Breast Cancer Translational Research Group, Jules Bordet Institute, Brussels. · Molecular Immunology Lab, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre University of Melbourne, East Melbourne, Victoria, Australia. · Institute of Pathology Charité University Hospital, Berlin, Germany and German Cancer Consortium, Berlin, Germany. · Pubmed 28426105
  • Peter MacCallum Cancer Centre, Melbourne. · Latrobe Regional Hospital, Traralgon. · University of Melbourne, Melbourne, Australia. · Pubmed 28430863
2015
  • Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet, Brussels Department of Pathology and TCRU, GZA, Antwerp, Belgium. · Institute of Pathology, Charité -University Hospital, Berlin, Germany. · Perlmutter Cancer Center, New York University Medical School, New York, USA. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · European Institute of Oncology (IEO) and University of Milan, Milan, Italy. · Department of Pathology GZA, TCRU Hospitals and CORE Antwerp University, Antwerp, Belgium. · Genomic Health, Inc., Redwood City, USA University of California San Francisco, San Francisco, USA. · Clermont-Ferrand Biopathology, University of Auvergne, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · Division of Haematology/Medical Oncology and. · Department of Cancer Biology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Jacksonville. · Department of Pathology, The UT M.D. Anderson Cancer Center, Boston. · Department of Pathology, Brigham and Women's Hospital, Boston Department of Cancer Biology, Dana Farber Cancer Institute, Boston. · Department of Cancer Biology, Dana Farber Cancer Institute, Boston Department of Cancer Biology, Harvard Medical School, Boston, USA. · Istituto Europeo di Oncologia, Milan, Italy. · Genomic Health, Inc., Redwood City, USA. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels. · Department of Pathology, University Hospital Leuven, Leuven, Belgium. · Department of Medicine, Department of Obstetrics and Gynecology and Women's Health, Albert Einstein Medical Center, Bronx, USA. · Laboratory Medicine Program, University Health Network, University of Toronto, Toronto. · Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, Canada. · Department of Pathology, Yale University School of Medicine, New Haven. · Department of Pathology, Stanford University Medical Centre, Stanford. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, USA. · German Breast Group, Neu-Isenburg, Germany. · Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan, Italy. · Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, USA. · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Victoria, Australia · Pubmed 25214542
Probable:    Jules Bordet Institute      
2014
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne,Australia · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium Service de Biostatistique et D'Epidemiology, Gustave Roussy, Universite Paris-Sud, Villejuif, France. · Department of Anatomical Pathology, Institut Jules Bordet, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Oncology, Tampere University Hospital, Tampere. · Department of Oncology, Helsinki University Central Hospital, Helsinki. · Cancer Center, Kuopio University Hospital, Kuopio, Finland. · Department of Medicine, Institut Jules Bordet, Brussels, Belgium. · German Breast Group, Neu-Isenburg. · Charité University Hospital, Institute of Pathology, Berlin, Germany. · Immunology in Cancer and Infection Laboratory, Queensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute; School of Medicine, University of Queensland, Herston, Australia. · Pubmed 24608200
2013
  • Department of Medicine, Institute Jules Bordet, L'Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 22910839
  • Breast Cancer Translational Research Laboratory BCTL, J.C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23337633
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 12 total) written by S. Loi about Breast Neoplasms:

  • The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast. 2017
  • Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial. 2017
  • FGFR2 amplification in metastatic hormone-positive breast cancer and response to an mTOR inhibitor. 2017
  • Quality of life with palbociclib plus fulvestrant in previously treated hormone receptor-positive, HER2-negative metastatic breast cancer: patient-reported outcomes from the PALOMA-3 trial. 2016
  • Somatic mutation, copy number and transcriptomic profiles of primary and matched metastatic estrogen receptor-positive breast cancers. 2016
  • PIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective trials investigating lapatinib and trastuzumab. 2016
  • The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. 2015
  • Immunity and HER2-positive disease: never stop questioning. 2015
  • Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial. 2014
  • Pertuzumab: new hope for patients with HER2-positive breast cancer. 2013
Show List of Full Article Records
Google Searches

Learn more about S. Loi using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Peter MacCallum Cancer Centre
University of Melbourne
Jules Bordet Institute
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Peter MacCallum Cancer Centre
2017
  • Department of Pathology, European Institute of Oncology, Milan. · School of Medicine, University of Milan, Milan. · Cancer Prevention and Genetics, European Institute of Oncology, Milan. · Epidemiology and Biostatistics, European Institute of Oncology, Milan. · Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan. · Division of Medical Oncology, E.O. Ospedali Galliera, Genoa. · Experimental Therapeutics European Institute of Oncology, Milan. · Division of Senology, European Institute of Oncology, Milan, Italy. · Department of Pathology, GZA, Breast Cancer Translational Research Group, Jules Bordet Institute, Brussels. · Molecular Immunology Lab, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre University of Melbourne, East Melbourne, Victoria, Australia. · Institute of Pathology Charité University Hospital, Berlin, Germany and German Cancer Consortium, Berlin, Germany. · Pubmed 28426105
  • Department of Breast Medical Oncology, Yale University, Yale Cancer Center, New Haven, USA. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Frontier Science, Inverness, Scotland. · Breast Center, Department of Obstetrics and Gynecology, University of Munich, Germany. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Spanish Breast Cancer Cooperative Group SOLTI, Barcelona, Spain. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Australia. · Hospital Moinhos de Vento, Porto Alegre, Brazil. · Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada. · The Christie/NIHR Clinical Research Facility, Manchester, UK. · Department of Breast Surgery, Kyoto University Hospital, Kyoto, Japan. · Department of Obstetrics and Gynecology, Campus Kiel, University Hospital Kiel, Kiel, Germany. · Novartis, Cambridge. · Memorial Sloan-Kettering Cancer Center, Memorial Hospital, New York, USA. · Pubmed 28177460
  • Peter MacCallum Cancer Centre, Melbourne. · Latrobe Regional Hospital, Traralgon. · University of Melbourne, Melbourne, Australia. · Pubmed 28430863
2016
  • Department of Obstetrics and Gynecology, Brustzentrum der Universität München, München (LMU), Germany · Pfizer Inc, New York, USA. · Department of Molecular Oncology, Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Department of Medical Oncology, Thomas Jefferson University, Philadelphia, USA. · Department of Medicine, National Cancer Center, Goyang-si, Korea. · Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. · Department of Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia. · Department of Medicine, Sunnybrook Odette Cancer Centre, Toronto, Canada. · Department of Transfusion, Aichi Cancer Center Hospital, Nagoya, Japan. · Pfizer Inc, Cambridge, USA. · Department of Oncology, German Breast Group Forschungs GmbH, Neu-Isenburg, Germany. · Pubmed 27029704
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Free University of Bruxelles, Brussels, Belgium. · Oncology Biomarker Development, Genentech Inc., South San Francisco, CA, USA. · Department of Biostatistics, Genentech Inc., South San Francisco, CA, USA. · Division of Early Drug Development for Innovative Therapies, European Institute of Oncology, Milan, Italy. · Department of Pathology, Institut Jules Bordet, Brussels, Belgium. · Breast International Group, Brussels, Belgium. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Division of Medical Oncology, Institut Jules Bordet, Brussels, Belgium. · Division of Biostatistics and Epidemiology, Institut Gustave Roussy, Villejuif, France INSERM U1018, CESP, University of Paris, Villejuif, France. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Free University of Bruxelles, Brussels, Belgium Division of Medical Oncology, Institut Jules Bordet, Brussels, Belgium. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia · Pubmed 27672107
  • German Breast Group, Neu-Isenburg, Germany · The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Surgery, Oncology and Gastroenterology, University of Padua, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · German Breast Group, Neu-Isenburg, Germany. · Frontier Science Scotland, Kincraig, UK. · Department of Medical Oncology, University of Verona, Verona, Italy. · Institute of Pathology, Charité Universitätsmedizin Berlin, and German Cancer Consortium (DKTK), Berlin. · Department of Obstetrics and Gynecology, University Hospital Kiel, Kiel, Germany. · Institut Jules Bordet, Université Libre de Bruxelles, Brussel, Belgium. · Peter MacCallum Cancer Centre, East Melbourne, Australia. · Department of Obstetrics and Gynecology, Helios-Klinikum, Berlin-Buch, Germany. · Memorial Sloan-Kettering Cancer Center, New York, USA. · Pubmed 27177864
2015
  • Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet, Brussels Department of Pathology and TCRU, GZA, Antwerp, Belgium. · Institute of Pathology, Charité -University Hospital, Berlin, Germany. · Perlmutter Cancer Center, New York University Medical School, New York, USA. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · European Institute of Oncology (IEO) and University of Milan, Milan, Italy. · Department of Pathology GZA, TCRU Hospitals and CORE Antwerp University, Antwerp, Belgium. · Genomic Health, Inc., Redwood City, USA University of California San Francisco, San Francisco, USA. · Clermont-Ferrand Biopathology, University of Auvergne, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · Division of Haematology/Medical Oncology and. · Department of Cancer Biology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Jacksonville. · Department of Pathology, The UT M.D. Anderson Cancer Center, Boston. · Department of Pathology, Brigham and Women's Hospital, Boston Department of Cancer Biology, Dana Farber Cancer Institute, Boston. · Department of Cancer Biology, Dana Farber Cancer Institute, Boston Department of Cancer Biology, Harvard Medical School, Boston, USA. · Istituto Europeo di Oncologia, Milan, Italy. · Genomic Health, Inc., Redwood City, USA. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels. · Department of Pathology, University Hospital Leuven, Leuven, Belgium. · Department of Medicine, Department of Obstetrics and Gynecology and Women's Health, Albert Einstein Medical Center, Bronx, USA. · Laboratory Medicine Program, University Health Network, University of Toronto, Toronto. · Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, Canada. · Department of Pathology, Yale University School of Medicine, New Haven. · Department of Pathology, Stanford University Medical Centre, Stanford. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, USA. · German Breast Group, Neu-Isenburg, Germany. · Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan, Italy. · Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, USA. · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Victoria, Australia · Pubmed 25214542
  • Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia · Pubmed 26487579
2014
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne,Australia · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium Service de Biostatistique et D'Epidemiology, Gustave Roussy, Universite Paris-Sud, Villejuif, France. · Department of Anatomical Pathology, Institut Jules Bordet, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Oncology, Tampere University Hospital, Tampere. · Department of Oncology, Helsinki University Central Hospital, Helsinki. · Cancer Center, Kuopio University Hospital, Kuopio, Finland. · Department of Medicine, Institut Jules Bordet, Brussels, Belgium. · German Breast Group, Neu-Isenburg. · Charité University Hospital, Institute of Pathology, Berlin, Germany. · Immunology in Cancer and Infection Laboratory, Queensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute; School of Medicine, University of Queensland, Herston, Australia. · Pubmed 24608200
University of Melbourne
2017
  • Department of Pathology, European Institute of Oncology, Milan. · School of Medicine, University of Milan, Milan. · Cancer Prevention and Genetics, European Institute of Oncology, Milan. · Epidemiology and Biostatistics, European Institute of Oncology, Milan. · Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan. · Division of Medical Oncology, E.O. Ospedali Galliera, Genoa. · Experimental Therapeutics European Institute of Oncology, Milan. · Division of Senology, European Institute of Oncology, Milan, Italy. · Department of Pathology, GZA, Breast Cancer Translational Research Group, Jules Bordet Institute, Brussels. · Molecular Immunology Lab, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre University of Melbourne, East Melbourne, Victoria, Australia. · Institute of Pathology Charité University Hospital, Berlin, Germany and German Cancer Consortium, Berlin, Germany. · Pubmed 28426105
  • Peter MacCallum Cancer Centre, Melbourne. · Latrobe Regional Hospital, Traralgon. · University of Melbourne, Melbourne, Australia. · Pubmed 28430863
2015
  • Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet, Brussels Department of Pathology and TCRU, GZA, Antwerp, Belgium. · Institute of Pathology, Charité -University Hospital, Berlin, Germany. · Perlmutter Cancer Center, New York University Medical School, New York, USA. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · European Institute of Oncology (IEO) and University of Milan, Milan, Italy. · Department of Pathology GZA, TCRU Hospitals and CORE Antwerp University, Antwerp, Belgium. · Genomic Health, Inc., Redwood City, USA University of California San Francisco, San Francisco, USA. · Clermont-Ferrand Biopathology, University of Auvergne, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · Division of Haematology/Medical Oncology and. · Department of Cancer Biology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Jacksonville. · Department of Pathology, The UT M.D. Anderson Cancer Center, Boston. · Department of Pathology, Brigham and Women's Hospital, Boston Department of Cancer Biology, Dana Farber Cancer Institute, Boston. · Department of Cancer Biology, Dana Farber Cancer Institute, Boston Department of Cancer Biology, Harvard Medical School, Boston, USA. · Istituto Europeo di Oncologia, Milan, Italy. · Genomic Health, Inc., Redwood City, USA. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels. · Department of Pathology, University Hospital Leuven, Leuven, Belgium. · Department of Medicine, Department of Obstetrics and Gynecology and Women's Health, Albert Einstein Medical Center, Bronx, USA. · Laboratory Medicine Program, University Health Network, University of Toronto, Toronto. · Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, Canada. · Department of Pathology, Yale University School of Medicine, New Haven. · Department of Pathology, Stanford University Medical Centre, Stanford. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, USA. · German Breast Group, Neu-Isenburg, Germany. · Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan, Italy. · Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, USA. · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Victoria, Australia · Pubmed 25214542
Jules Bordet Institute
2014
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne,Australia · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium Service de Biostatistique et D'Epidemiology, Gustave Roussy, Universite Paris-Sud, Villejuif, France. · Department of Anatomical Pathology, Institut Jules Bordet, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Oncology, Tampere University Hospital, Tampere. · Department of Oncology, Helsinki University Central Hospital, Helsinki. · Cancer Center, Kuopio University Hospital, Kuopio, Finland. · Department of Medicine, Institut Jules Bordet, Brussels, Belgium. · German Breast Group, Neu-Isenburg. · Charité University Hospital, Institute of Pathology, Berlin, Germany. · Immunology in Cancer and Infection Laboratory, Queensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute; School of Medicine, University of Queensland, Herston, Australia. · Pubmed 24608200
2013
  • Department of Medicine, Institute Jules Bordet, L'Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 22910839
  • Breast Cancer Translational Research Laboratory BCTL, J.C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23337633
Universite Libre de Bruxelles
2014
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne,Australia · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium Service de Biostatistique et D'Epidemiology, Gustave Roussy, Universite Paris-Sud, Villejuif, France. · Department of Anatomical Pathology, Institut Jules Bordet, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Oncology, Tampere University Hospital, Tampere. · Department of Oncology, Helsinki University Central Hospital, Helsinki. · Cancer Center, Kuopio University Hospital, Kuopio, Finland. · Department of Medicine, Institut Jules Bordet, Brussels, Belgium. · German Breast Group, Neu-Isenburg. · Charité University Hospital, Institute of Pathology, Berlin, Germany. · Immunology in Cancer and Infection Laboratory, Queensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute; School of Medicine, University of Queensland, Herston, Australia. · Pubmed 24608200
2013
  • Breast Cancer Translational Research Laboratory BCTL, J.C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23337633
Miscellaneous institutions in Dijon
2012
  • Department of Medical Oncology, Georges-François Leclerc Cancer Center, Dijon, France. · Pubmed 23166150
Yearly article counts 003321210000
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.